Fluocinolone

DB12553InvestigationalSmall molecule

Fluocinolone has been used in trials studying the treatment and prevention of Candida Infection, Oral Lichen Planus, Macular Degeneration, and Choroidal Neovascularization.

Mechanism: Pharmacologically active on Glucocorticoid receptor
Curator reviewed
Formula / weight: C₂₁H₂₆F₂O₆ · 412.43 g/mol (avg)

Resolves to

Compound

UNIICT1IX58L9SCAS807-38-5ChEMBLCHEMBL1201390ChEBI5108PubChem91488KEGGC07006

Clinical / RWD

RxNorm25126

Structure

InChIKeyUUOUOERPONYGOS-CLCRDYEYSA-NSMILESC[C@]12C[C@H](O)[C@@]3(F)[C@@H](C[C@H](F)C4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO

Targets

P04150NR3C1

What you can answer from here — as of July 10, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Fluocinolone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account